Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK.

Osteoporos Int. 2017 Dec 3. doi:10.1007/s00198-017-4308-5.

Martín-Merino E, Petersen I, Hawley S, Álvarez-Gutierrez A, Khalid S,Llorente-Garcia A, Delmestri A, Javaid MK, Van Staa TP, Judge A, Cooper C,Prieto-Alhambra D.

Más información